These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27147826)

  • 1. Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome.
    von Arnim U; Wex T; Ganzert C; Schulz C; Malfertheiner P
    Clin Exp Gastroenterol; 2016; 9():97-103. PubMed ID: 27147826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microscopic Colitis: A Diagnostic Challenge in Patients with Irritable Bowel Syndrome.
    Rusu F; Caragut RL; Mocanu LC; Leucuta DC; Dumitrascu DL
    J Gastrointestin Liver Dis; 2023 Dec; 32(4):469-472. PubMed ID: 38147615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is fecal calprotectin always normal in children with irritable bowel syndrome?
    Choi YJ; Jeong SJ
    Intest Res; 2019 Oct; 17(4):546-553. PubMed ID: 31467259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irritable bowel syndrome-like symptoms in treated microscopic colitis patients compared with controls: a cross-sectional study.
    Pagoldh J; Lundgren D; Suhr OB; Karling P
    Gastroenterol Rep (Oxf); 2020 Oct; 8(5):374-380. PubMed ID: 33163193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal calprotectin is a useful marker to diagnose ulcerative colitis from irritable bowel syndrome.
    Kalantari H; Taheri A; Yaran M
    Adv Biomed Res; 2015; 4():85. PubMed ID: 26015911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients With Inflammatory Bowel Disease.
    Gracie DJ; Williams CJ; Sood R; Mumtaz S; Bholah MH; Hamlin PJ; Ford AC
    Clin Gastroenterol Hepatol; 2017 Mar; 15(3):376-384.e5. PubMed ID: 27189912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls.
    Lundgren D; Rutegård J; Eklöf V; Palmqvist R; Karling P
    BMC Gastroenterol; 2016 Nov; 16(1):139. PubMed ID: 27881072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal calprotectin levels after rifaximin treatment in patients with irritable bowel syndrome with diarrhoea: A single-center prospective study.
    Safwat E; Salah M; Hussein H
    Arab J Gastroenterol; 2020 Dec; 21(4):273-277. PubMed ID: 32928705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome.
    Sydora MJ; Sydora BC; Fedorak RN
    J Crohns Colitis; 2012 Mar; 6(2):207-14. PubMed ID: 22325175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fecal calprotectin in differential diagnosis of irritable bowel syndrome].
    Li XG; Lu YM; Gu F; Yang XL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):310-3. PubMed ID: 16778979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microscopic colitis - a missed diagnosis in diarrhea-predominant irritable bowel syndrome.
    Stoicescu A; Becheanu G; Dumbrava M; Gheorghe C; Diculescu M
    Maedica (Bucur); 2012 Jan; 7(1):3-9. PubMed ID: 23118812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of microscopic colitis in patients with irritable bowel syndrome with diarrhea predominance].
    Carmona-Sánchez R; Carrera-Álvarez MA; Pérez-Aguilar RM
    Rev Gastroenterol Mex; 2011; 76(1):39-45. PubMed ID: 21592902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does fecal calprotectin increase may be linked to lactose intolerance in patients with irritable bowel syndrome?
    Guingand DE Rivery M; Zeinab H; Cohen V; Baumstarck K; Luciano L; Vitton V
    Minerva Gastroenterol (Torino); 2023 Sep; 69(3):329-334. PubMed ID: 33829725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
    Langhorst J; Junge A; Rueffer A; Wehkamp J; Foell D; Michalsen A; Musial F; Dobos GJ
    Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic overlap in patients with diarrhea predominant irritable bowel syndrome and microscopic colitis in a sub group of Bangladeshi population.
    Rahman MA; Raihan AS; Ahamed DS; Masud H; Safiullah AB; Khair KB; Salimullah AS; Islam MM
    Bangladesh Med Res Counc Bull; 2012 Apr; 38(1):33-8. PubMed ID: 22545349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The frequency of microscopic and focal active colitis in patients with irritable bowel syndrome.
    Ozdil K; Sahin A; Calhan T; Kahraman R; Nigdelioglu A; Akyuz U; Sokmen HM
    BMC Gastroenterol; 2011 Aug; 11():96. PubMed ID: 21880133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
    Kotze LM; Nisihara RM; Marion SB; Cavassani MF; Kotze PG
    Arq Gastroenterol; 2015; 52(1):50-4. PubMed ID: 26017083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal calprotectin levels in children is more tightly associated with histological than with macroscopic endoscopy findings.
    Hradsky O; Ohem J; Mitrova K; Durilova M; Kotalova R; Nevoral J; Kolho KL; Bronsky J
    Clin Lab; 2014; 60(12):1993-2000. PubMed ID: 25651733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS.
    Di Nardo G; Barbara G; Cucchiara S; Cremon C; Shulman RJ; Isoldi S; Zecchi L; Drago L; Oliva S; Saulle R; Barbaro MR; Stronati L
    Neurogastroenterol Motil; 2014 Feb; 26(2):196-204. PubMed ID: 24304324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.